Cite
HARVARD Citation
Spigel, D. et al. (2018). Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium. Lung cancer. pp. 38-43. [Online].